Mr. CSN Murthy

Chief Executive Officer, Aurigene Discovery Technologies Ltd.

Mr. CSN Murthy began his career with ICICI Ventures, India's first Venture Capital fund. He was subsequently a management consultant to the Pharma and Chemical sectors. Later, he worked in the Business Development and General Management functions in Pharmaceutical companies, including as the Chief Operating Officer of Gland Pharma Ltd. CSN holds a Bachelors degree in Chemical Engineering from the Indian Institute of Technology (IIT), Madras and an MBA from the Indian Institute of Management (IIM), Bangalore.

Dr.Thomas Antony

Associate Research Director, Aurigene Discovery Technologies Ltd.

Dr.Thomas Antony did his Ph.D in Biophysical Chemistry from University of Delhi and had his postdoctoral training at Jawaharlal Nehru University- Delhi, The University of Medicine and Dentistry of New Jersey- USA, and Max Planck Institute for Biophysical Chemistry- Germany. He is the recipient of many research fellowships, including Max Planck Fellowship and Humboldt Research Fellowship.  He has more than 20 years of research experience. Dr.Thomas has published 24 research papers and he is the co-author of three international patents. His core area of expertise is in assay development and screening. At Aurigene, Dr.Thomas leads the Biochemistry and Structural Biology Divisions.  He was the coordinator of Aurigene-University of Malaya collaboration programs.   

Dr. Kavitha Nellore

Associate Research Director, Aurigene Discovery Technologies Ltd. 

Dr. Kavitha Nellore obtained her PhD in Bioengineering from Pennsylvania State University, USA.  During this time, she was a fellow of the Huck’s Institute of Life Sciences specializing in Biomolecular Transport Dynamics. She has been at Aurigene for more than a decade, and is currently leading a group of cell biologists at both Bangalore and Kuala Lumpur. At Aurigene, she leads multiple drug discovery programs in the therapeutic areas of inflammation, oncology and immuno-oncology. She plays a key role in target selection as well as validation efforts to add to Aurigene’s pipeline. Kavitha also played a key role in coordinating the Aurigene-University of Malaya collaboration. 

Prof. Habibah A Wahab

School of Pharmaceutical Sciences, Universiti Sains Malaysia

Immediately after obtaining her PhD from King’s College London in 1999, Habibah joined Universiti Sains Malaysia, as a lecturer at the School of Pharmaceutical Sciences where she actively researches on drug discovery especially those utilizing computational chemistry and computer aided drug design approaches. Her current disease research areas include dengue and ageing. Habibah has also been active in communicating her research work in her presentations as Keynotes, Plenary and Invited speakers in many international conferences as well as in over 100 articles in international publications. Since 2014, Habibah has been serving as an Associate Editor for Journal of Chemical Information and Modeling, an American Chemical Society publication. This Q1 Journal specially focused in the development of computational methods and analyses related to drug discovery.